Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L WALTON

Showing results (401-410 of 517) with videos related to

Pageof 52
Sort By:
Social Science & Medicine (1982)|September 20, 2025
Intersecting social inequalities in prenatal and postnatal care: Examining race, ethnicity, socioeconomic status, and geographic locationNeema Langa, Kathryn Freeman Anderson, Zelma Oyarvide Tuthill, et al.
Cancer Medicine|May 22, 2019
Barriers to obtaining prostate multi-parametric magnetic resonance imaging in African-American men on active surveillance for prostate cancerEric L Walton, Mustafa Deebajah, Jacob Keeley, et al.
The Journal of Biological Chemistry|May 1, 2020
A variant of human growth differentiation factor-9 that improves oocyte developmental competenceWilliam A Stocker, Kelly L Walton, Dulama Richani, et al.
Acta Neuropathologica Communications|July 12, 2023
Publisher Correction to: Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologiesShunsuke Koga, Aya Murakami, Alexandra I Soto-Beasley, et al.
Acta Neuropathologica Communications|July 6, 2023
Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologiesShunsuke Koga, Aya Murakami, Alexandra I Soto-Beasley, et al.
The Journal of Clinical Endocrinology and Metabolism|March 31, 2017
BMP15 Mutations Associated With Primary Ovarian Insufficiency Reduce Expression, Activity, or Synergy With GDF9Liliana C Patiño, Kelly L Walton, Thomas D Mueller, et al.
ACS Pharmacology & Translational Science|April 8, 2020
Serelaxin and the AT<sub>2</sub> Receptor Agonist CGP42112 Evoked a Similar, Nonadditive, Cardiac Antifibrotic Effect in High Salt-Fed Mice That Were Refractory to Candesartan CilexetilYan Wang, Lei Han, Matthew Shen, et al.
Osteoarthritis and Cartilage|December 20, 2024
A programmable arthritis-specific receptor for guided articular cartilage regenerative medicineBonnie L Walton, Rebecca Shattuck-Brandt, Catherine A Hamann, et al.
Gut Microbes|September 1, 2022
Bezlotoxumab prevents extraintestinal organ damage induced by <i>Clostridioides difficile</i> infectionSteven J Mileto, Melanie L Hutton, Sarah L Walton, et al.
Molecular and Cellular Endocrinology|December 22, 2015
Biological activity and in vivo half-life of pro-activin A in male ratsKatharine E Johnson, Yogeshwar Makanji, Peter Temple-Smith, et al.
Pageof 52

Showing results (401-410 of 517) with videos related to

Sort By:
Pageof 52
Social Science & Medicine (1982)|September 20, 2025
Intersecting social inequalities in prenatal and postnatal care: Examining race, ethnicity, socioeconomic status, and geographic locationNeema Langa, Kathryn Freeman Anderson, Zelma Oyarvide Tuthill, et al.
Cancer Medicine|May 22, 2019
Barriers to obtaining prostate multi-parametric magnetic resonance imaging in African-American men on active surveillance for prostate cancerEric L Walton, Mustafa Deebajah, Jacob Keeley, et al.
The Journal of Biological Chemistry|May 1, 2020
A variant of human growth differentiation factor-9 that improves oocyte developmental competenceWilliam A Stocker, Kelly L Walton, Dulama Richani, et al.
Acta Neuropathologica Communications|July 12, 2023
Publisher Correction to: Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologiesShunsuke Koga, Aya Murakami, Alexandra I Soto-Beasley, et al.
Acta Neuropathologica Communications|July 6, 2023
Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologiesShunsuke Koga, Aya Murakami, Alexandra I Soto-Beasley, et al.
The Journal of Clinical Endocrinology and Metabolism|March 31, 2017
BMP15 Mutations Associated With Primary Ovarian Insufficiency Reduce Expression, Activity, or Synergy With GDF9Liliana C Patiño, Kelly L Walton, Thomas D Mueller, et al.
ACS Pharmacology & Translational Science|April 8, 2020
Serelaxin and the AT<sub>2</sub> Receptor Agonist CGP42112 Evoked a Similar, Nonadditive, Cardiac Antifibrotic Effect in High Salt-Fed Mice That Were Refractory to Candesartan CilexetilYan Wang, Lei Han, Matthew Shen, et al.
Osteoarthritis and Cartilage|December 20, 2024
A programmable arthritis-specific receptor for guided articular cartilage regenerative medicineBonnie L Walton, Rebecca Shattuck-Brandt, Catherine A Hamann, et al.
Gut Microbes|September 1, 2022
Bezlotoxumab prevents extraintestinal organ damage induced by <i>Clostridioides difficile</i> infectionSteven J Mileto, Melanie L Hutton, Sarah L Walton, et al.
Molecular and Cellular Endocrinology|December 22, 2015
Biological activity and in vivo half-life of pro-activin A in male ratsKatharine E Johnson, Yogeshwar Makanji, Peter Temple-Smith, et al.
Pageof 52